Dr Reddy’s gets four observations from USFDA for Andhra Plant

The audit of the Dr Reddy’s Laboratories’ formulations Srikakulum Plant (SEZ) Unit I, Andhra Pradesh by the US Food and Drug Administration (USFDA), has been completed. The company has received four observations from the US health regulator after the inspection. As per the USFDA, a Form 483 is issued to a firm’s management at the conclusion of an inspection when an investigator has observed any conditions that in its judgment may constitute violations of the Food Drug and Cosmetic (FD&C) Act and related Acts. It notifies the company’s management of objectionable conditions.